Please login to the form below

Not currently logged in

Real-world studies

Bill Row

by Bill Row

Three steps forward, four steps back

JessHow to ensure digital content achieves the right dialogue

Embracing technology and analytics

By Diane Wass

Rare disease trials Q&A

By Gretchen Goller and Valerie Legrand

Lonely planet: why there is dwindling value in pharma travelling alone

MapTo develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...